Please login to the form below
Karuna Therapeutics
This page shows the latest Karuna Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Intra-Cellular soars on FDA approval of schizophrenia drug
Shares rocketed following the announcement. US biotech Intra-Cellular Therapeutics has scored approval for its antipsychotic drug Caplyta for the treatment of schizophrenia, to the delight of investors. ... This includes Sage Therapeutics, Acadia
Latest news
-
Karuna’s shares spike on schizophrenia drug data
Value leaps to more than $1bn following mid-stage trial results. Just five months after its stock market debut, Karuna Therapeutics has seen its value leap to more than $1bn on ... initiate a phase 3 clinical trial of KarXT in patients with schizophrenia
-
Daily Brief: another departure at Gilead, veteran researcher to head up Karuna
Veteran researcher to head up Karuna’s antipsychotic push. Karuna's new CEO Steven Paul. ... Boston, Mass-based Karuna Pharmaceuticals is focused on targeting muscarinic cholinergic receptors for the treatment of neuropsychiatric disorders marked by
-
Daily Brief: Karuna raises $42m for novel CNS approach, Chen exits Roche, Orchard gains GSK board member
The latest from pharma, biotech and healthcare. ‘Game changing CNS’ company Karuna raises $42m. ... Karuna has all of the characteristics we look for in a game-changing CNS company.
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- NHS App to revolutionise digital health and care with major digital updates by 2023
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Early communications in Pharma: How effective pre-approval comms delivers launch success
- Create Health Showreel
- AstraZeneca acquires TeneoTwo in a deal worth up to $1.27bn
- Cancer Research UK urges government to realise ‘science superpower’ ambitions as new report highlights ‘huge’ economic value
- Novartis UK launches first health-tech investor partnership to address cardiovascular care
- UK government invests £175m to ‘supercharge’ clinical research
- A creative awakening – how pharma is bringing innovation to the patient journey
- European Commission approves potential new treatment for Pompe disease
- Sanofi Global Health unveils new nonprofit Impact brand
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Novartis UK launches first health-tech investor partnership to address cardiovascular care
PMHub
Health Unlimited
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...
Latest intelligence
- Early communications in Pharma: How effective pre-approval comms delivers launch success
- What communications are required for a successful launch...
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
